Cargando…
Adverse Skin Reactions due to Ribavirin in Hepatitis C Combination Therapy with Pegylated Interferon-α(2a)
The introduction of ribavirin to hepatitis C combination therapy with pegylated interferon (PEG-IFN)-α(2a) has improved sustained responses, but it has been accompanied by an increased incidence of cutaneous side effects. Most cases of drug eruption caused by ribavirin and PEG-IFN-α(2) or IFN-α comb...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
S. Karger AG
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3919427/ https://www.ncbi.nlm.nih.gov/pubmed/24516409 http://dx.doi.org/10.1159/000357516 |